{"schema_version":"secwatch.filing_event.v1","accession":"0000856982-26-000023","form_type":"8-K","ticker":"MMSI","cik":"0000856982","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.824560+00:00","generated_at":"2026-05-15T01:23:36.906723+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Merit Medical Q1 beat: rev $381.9M, EPS $0.94 non-GAAP; acquires View Point Medical for $140M","bullets":["Revenue $381.9M (+7%); GAAP EPS $0.68 (+39%); non-GAAP EPS $0.94 (+9%).","Non-GAAP operating margin 19.7% (up 40 bps); free cash flow $24.7M (+26%).","Acquired View Point Medical (OneMark) for $140M on Apr 1; sold DualCap product line for $28M in Feb.","Reorganized revenue reporting into Foundational and Therapeutic; updated full-year guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0000856982-26-000023","json":"https://secwatch.observer/filing/0000856982-26-000023.json","markdown":"https://secwatch.observer/filing/0000856982-26-000023.md","text":"https://secwatch.observer/filing/0000856982-26-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856982/000085698226000023/0000856982-26-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856982/000085698226000023/mmsi-20260430x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T01:23:36.906723+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"be0d731748ed10124924a8eb861a0410b1d5ceef","claim":"MERIT MEDICAL SYSTEMS INC reported the quarter ended March 31, 2026 results: revenue $381.9 million, EPS GAAP EPS $0.68.","evidence_excerpt":"​ ​ ​ ​ ​ ​ FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS FIRST QUARTER 2026 RESULTS AND UPDATES FULL-YEAR GUIDANCE ​ Financial Highlights† ● Reported revenue of $381.9 million, up 7% ● Constant currency revenue* and constant currency revenue, organic* up 5% and up 3%, respectively o Constant currency revenue, organic* increased 4%, excluding revenue","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/856982/000085698226000023/0000856982-26-000023-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"Revenue","value":"$381.9 million"},{"label":"EPS","value":"GAAP EPS $0.68"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}